X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
55
PharmaCompass offers a list of Chlordiazepoxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Chlordiazepoxide manufacturer or Chlordiazepoxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Chlordiazepoxide manufacturer or Chlordiazepoxide supplier.
PharmaCompass also assists you with knowing the Chlordiazepoxide API Price utilized in the formulation of products. Chlordiazepoxide API Price is not always fixed or binding as the Chlordiazepoxide Price is obtained through a variety of data sources. The Chlordiazepoxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MolPort-002-051-367 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-002-051-367, including repackagers and relabelers. The FDA regulates MolPort-002-051-367 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-002-051-367 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MolPort-002-051-367 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MolPort-002-051-367 supplier is an individual or a company that provides MolPort-002-051-367 active pharmaceutical ingredient (API) or MolPort-002-051-367 finished formulations upon request. The MolPort-002-051-367 suppliers may include MolPort-002-051-367 API manufacturers, exporters, distributors and traders.
click here to find a list of MolPort-002-051-367 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MolPort-002-051-367 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-002-051-367 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-002-051-367 DMFs exist exist since differing nations have different regulations, such as MolPort-002-051-367 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MolPort-002-051-367 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-002-051-367 USDMF includes data on MolPort-002-051-367's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-002-051-367 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MolPort-002-051-367 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The MolPort-002-051-367 Drug Master File in Japan (MolPort-002-051-367 JDMF) empowers MolPort-002-051-367 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the MolPort-002-051-367 JDMF during the approval evaluation for pharmaceutical products. At the time of MolPort-002-051-367 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of MolPort-002-051-367 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a MolPort-002-051-367 Drug Master File in Korea (MolPort-002-051-367 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of MolPort-002-051-367. The MFDS reviews the MolPort-002-051-367 KDMF as part of the drug registration process and uses the information provided in the MolPort-002-051-367 KDMF to evaluate the safety and efficacy of the drug.
After submitting a MolPort-002-051-367 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their MolPort-002-051-367 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of MolPort-002-051-367 suppliers with KDMF on PharmaCompass.
A MolPort-002-051-367 CEP of the European Pharmacopoeia monograph is often referred to as a MolPort-002-051-367 Certificate of Suitability (COS). The purpose of a MolPort-002-051-367 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of MolPort-002-051-367 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of MolPort-002-051-367 to their clients by showing that a MolPort-002-051-367 CEP has been issued for it. The manufacturer submits a MolPort-002-051-367 CEP (COS) as part of the market authorization procedure, and it takes on the role of a MolPort-002-051-367 CEP holder for the record. Additionally, the data presented in the MolPort-002-051-367 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the MolPort-002-051-367 DMF.
A MolPort-002-051-367 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. MolPort-002-051-367 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of MolPort-002-051-367 suppliers with CEP (COS) on PharmaCompass.
A MolPort-002-051-367 written confirmation (MolPort-002-051-367 WC) is an official document issued by a regulatory agency to a MolPort-002-051-367 manufacturer, verifying that the manufacturing facility of a MolPort-002-051-367 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting MolPort-002-051-367 APIs or MolPort-002-051-367 finished pharmaceutical products to another nation, regulatory agencies frequently require a MolPort-002-051-367 WC (written confirmation) as part of the regulatory process.
click here to find a list of MolPort-002-051-367 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing MolPort-002-051-367 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for MolPort-002-051-367 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture MolPort-002-051-367 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain MolPort-002-051-367 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a MolPort-002-051-367 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of MolPort-002-051-367 suppliers with NDC on PharmaCompass.
MolPort-002-051-367 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MolPort-002-051-367 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MolPort-002-051-367 GMP manufacturer or MolPort-002-051-367 GMP API supplier for your needs.
A MolPort-002-051-367 CoA (Certificate of Analysis) is a formal document that attests to MolPort-002-051-367's compliance with MolPort-002-051-367 specifications and serves as a tool for batch-level quality control.
MolPort-002-051-367 CoA mostly includes findings from lab analyses of a specific batch. For each MolPort-002-051-367 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MolPort-002-051-367 may be tested according to a variety of international standards, such as European Pharmacopoeia (MolPort-002-051-367 EP), MolPort-002-051-367 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MolPort-002-051-367 USP).
Market Place
